ABDULHASSAN SAAD: Open Payments
NPI 1447546593 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 24 payments from 9 companies in 2025. Trend: 2023 $2,239 · 2024 $1,163 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $217 |
| PFIZER INC. | 3 | $59 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Amgen Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Orexo US, Inc. | 1 | $16 |
Products named: Wegovy, ELIQUIS, TRELEGY ELLIPTA, OTEZLA, Cologuard Collection Kit, AIRSUPRA, MOUNJARO, Fabhalta.
Industry payments across MI — which companies pay providers there.
